The American College of Radiology has halted efforts to move payment for screening mammography out of congressional control and into Medicare's relative value scale (RVS).Congress mandated reimbursement for screening mammography by Medicare and private
The American College of Radiology has halted efforts to move payment for screening mammography out of congressional control and into Medicare's relative value scale (RVS).
Congress mandated reimbursement for screening mammography by Medicare and private insurers as part of the Mammography Quality Standards Act of 1994. That law requires that Congress, not Medicare, set payment for the procedure. But in recent years, reimbursement has lagged far behind technical and professional costs to provide the service.
For example, standard two-view bilateral screening exams, which account for 70% of all breast imaging, are reimbursed at $66.81. Of that amount, $46.11 covers labor, equipment, supplies, and overhead. The remaining $20.70 goes to the mammographer for interpretation. The payment has increased only 7% since 1996.
The ACR had been working on the assumption that it might have a better chance at achieving incremental pay increases if the procedure was folded into the RVS. Screening mammography is the only Medicare-approved medical procedure that is not covered by the AMA's RVS process, according to Dr. William Thorwarth, chairman of the ACR Commission on Economics.
"We have had a real concern with relative values for breast imaging across the board," Thorwarth said. "We thought if we could get screening mammography incorporated into the RVS system, its value might be reconsidered and payment adjusted. But getting into that process can be unpredictable, and it's not known how long it might takeor what might happen once it was accepted."
Given the uncertainty about how payment for diagnostic mammography might change under Medicare's ambulatory payment classification program just going into effect, ACR executives decided they might have better luck lobbying Congress directly. Under the new payment system, which began to phase in Aug. 1, reimbursement for the technical aspect of diagnostic mammography is being ratcheted down and will now be reimbursed at a rate 26% lower than the entire payment for screening exams, Thorwarth said.
"It's unbelievable," he said, "especially since diagnostics take so much more tech time and room time, and all the labor and procedural costs are higher. Yet it's been assigned a lower value. We're concerned that will reduce access to diagnostic mammography, particularly for Medicare beneficiaries."
Since Congress felt strongly enough about screening mammography to enact a law protecting it, threats to access could support radiology's case for an upward pay adjustment.
"We're likely to be more effective in changing the reimbursement situation by working with Congress, not in this session but possibly in the next," Thorwarth said. "We will push to have screening mammography's value reconsidered, because Congress is aware of women's health needs and this is certainly a critical one."
Watch for an in-depth look at the mammography payment problem in the September issue of Diagnostic Imaging magazine. The article, "Small change for big medicine: The crisis in breast imaging services," explains how the quality of mammography in the U.S. is threatened by low reimbursement.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.